Identification of celastramycin as a novel therapeutic agent for pulmonary arterial hypertension -high-throughput screening of 5,562 compounds-
31 August 2019 (09:36 - 09:54)
Organised by:
About the speaker
RIKEN Center for Integrative Medical Sciences, Yokohama (Japan)
4 More presentations in this session
Professor M. Federici (Rome, IT)
Miss F. Zimmermann (Berlin, DE)
Professor S. Verma (Toronto, CA)
Professor R. Touyz (Montreal, CA)
Access the full session
The Event
ESC Congress 2019
31 August 2019
09:36 CET
